- Ordering

WES premature ovarian insufficiency

Type of exome analysis

Gene panel analysis

Gene panel analysis and exome wide analysis - 1 report

Form of analysis

Single analysis of proband only (DNA parents for storage) - TAT: 2-3 months

Trio/de novo analysis of proband and both parents - TAT: 2-3 months

Single analysis of proband only - TAT: 2-3 months

Rapid Trio/de novo analysis of proband and both parents - TAT: <15 business days

Rapid Single analysis of proband only - TAT: <15 business days

€ 750

Add Update Remove

WES premature ovarian insufficiency

This test is available for the following conditions:

Conditions > Endocrine > Premature ovarian failure
Conditions > Fertility and pregnancy > Premature ovarian insufficiency

Turnaround time
3 months

Method

Whole exome sequencing (WES)

Remarks
Voor premature ovariële insufficiëntie (POI/POF) wordt vaak ook de volgende test besteld:

The genes in this WES panel are also included in the WES panel Disorders/differences of sex development (DSD) / Primary adrenal insufficiency. This panel contains 32 genes.

Panel version: DG 3.6
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood (preferably), isolated DNA (only when EDTA blood is not an option)

Type of exome analysis

Gene panel analysis

Gene panel analysis and exome wide analysis - 1 report Panel analysis directly followed by an exome wide analysis (if the gene panel analysis does not reveal the genetic cause of the disorder)

Form of analysis

Single analysis of proband only (DNA parents for storage) - TAT: 2-3 months

Trio/de novo analysis of proband and both parents - TAT: 2-3 months

Single analysis of proband only - TAT: 2-3 months

Rapid Trio/de novo analysis of proband and both parents - TAT: <15 business days This test is designed for prenatal anomalies, newborn or early childhood (severe/life-threatening) conditions or conditions in need of gene specific treatment options.

Rapid Single analysis of proband only - TAT: <15 business days This test is designed for severe/life-threatening conditions or conditions in need of gene-specific treatment options AND when trio/de novo analysis is not an option or common practice.

€ 750

Add Update Remove

NR5A1 - premature ovarian failure

Premature ovarian failure

WES premature ovarian insufficiency

WES premature ovarian insufficiency

WES premature ovarian insufficiency

NR5A1 - premature ovarian failure

NR5A1 - premature ovarian failure

premature ovarian insufficiency (chromosome analysis)

premature ovarian insufficiency (chromosome analysis)

premature ovarian insufficiency (chromosome analysis)